UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 143

Sortiert nach

miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT

Oncogene, 2014-05, Vol.33 (19), p.2495-2503

2014

Volltextzugriff (PDF)

Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model

Oncogene, 2014-09, Vol.33 (36), p.4521-4530

2014

Volltextzugriff (PDF)

The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer

Oncogene, 2017-11, Vol.36 (46), p.6359-6373

2017

Volltextzugriff (PDF)

A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells

Oncogene, 2007-09, Vol.26 (41), p.6061-6070

2007

Volltextzugriff (PDF)

Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival

Oncogene, 2008-11, Vol.27 (56), p.7106-7117

2008

Volltextzugriff (PDF)

Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells

Oncogene, 2013-08, Vol.32 (35), p.4130-4138

2013

Volltextzugriff (PDF)

Inappropriate activation of androgen receptor by relaxin via β-catenin pathway

Oncogene, 2008-01, Vol.27 (4), p.499-505

2008

Volltextzugriff (PDF)

The Effect of Sirolimus on Prostate‐Specific Antigen (PSA) Levels in Male Renal Transplant Recipients Without Prostate Cancer

American journal of transplantation, 2008-12, Vol.8 (12), p.2668-2673

2008

Volltextzugriff (PDF)

p53 in Prostate Cancer: Frequent Expressed Transition Mutations

JNCI : Journal of the National Cancer Institute, 1994-06, Vol.86 (12), p.926-933

1994

Volltextzugriff (PDF)

Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors

Cancer, 1998-12, Vol.83 (12), p.2534-2539

1998

Volltextzugriff (PDF)

Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions

Urology, 2000-06, Vol.55 (6), p.800-806

2000

Volltextzugriff (PDF)

Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples

Advances in Virology, 2011-01, Vol.2011, p.272193-12

2011

Volltextzugriff (PDF)

Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia

Prostate cancer and prostatic diseases, 2004-12, Vol.7 (4), p.321-326

2004

Volltextzugriff (PDF)

Dehydroepiandrosterone Activates Mutant Androgen Receptors Expressed in the Androgen-Dependent Human Prostate Cancer Xenograft CWR22 and LNCaP Cells

Molecular endocrinology (Baltimore, Md.), 1997-04, Vol.11 (4), p.450-459

1997

Volltextzugriff (PDF)

Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy

International journal of radiation oncology, biology, physics, 2000-04, Vol.47 (1), p.115-119

2000

Volltextzugriff (PDF)

Inhibition of Akt pathways in the treatment of prostate cancer

Prostate cancer and prostatic diseases, 2007-12, Vol.10 (4), p.331-339

2007

Volltextzugriff (PDF)

Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer

The Journal of urology, 1995-08, Vol.154 (2), p.379-384

1995

Volltextzugriff (PDF)

Inappropriate activation of androgen receptor by relaxin via -catenin pathway

Oncogene, 2008-01, Vol.27 (4), p.499-505

2008

Volltextzugriff (PDF)

Tuberculous Spondylitis as A Complication of Intravesical Bacillus Calmette-Guerin Therapy

The Journal of urology, 1993-03, Vol.149 (3), p.584-587

1993

Volltextzugriff (PDF)

BCL2 antisense transcripts decrease intracellular Bcl2 expression and sensitize LNCaP prostate cancer cells to apoptosis-inducing agents

Cancer biotherapy & radiopharmaceuticals, 2001-10, Vol.16 (5), p.421-429

2001

Volltextzugriff (PDF)

Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation

Urology (Ridgewood, N.J.), 2000-04, Vol.55 (4), p.521-525

2000

Volltextzugriff (PDF)

Urinary Prostate Specific Antigen Levels: Role in Monitoring the Response of Prostate Cancer to Therapy

The Journal of urology, 1992-03, Vol.147 (3), p.947-951

1992

Volltextzugriff (PDF)

Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas

Clinical cancer research, 1997-10, Vol.3 (10), p.1889

1997

Volltextzugriff (PDF)

The Predictive Value of Flow Cytometric Information in the Clinical Management of Stage O (Ta) Bladder Cancer

The Journal of urology, 1988-02, Vol.139 (2), p.279-282

1988

Volltextzugriff (PDF)

Future prospects in prostate cancer

The Prostate, 1999-09, Vol.40 (4), p.261-268

1999

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(143)

Sprache

Englisch
(143)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(99)
Life Sciences & Biomedicine
(98)
Humans
(95)
Biological And Medical Sciences
(80)
Medical Sciences
(75)
Male
(73)
Urology & Nephrology
(57)
Nephrology. Urinary Tract Diseases
(48)
Tumors Of The Urinary System
(44)
Urinary Tract. Prostate Gland
(43)
Oncology
(29)
Prostate Cancer
(27)
Prostatic Neoplasms - Genetics
(27)
Flow Cytometry
(22)
Animals
(21)
Prostatic Neoplasms - Pathology
(21)
Aged
(19)
Middle Aged
(19)
Urinary Bladder Neoplasms - Pathology
(19)
Dna, Neoplasm - Analysis
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(30)
The Prostate
(11)
Urology
(11)
World Journal Of Urology
(9)
Journal Of Clinical Oncology
(8)
Oncogene
(8)
Jnci : Journal Of The National Cancer Institute
(6)
Cancer
(4)
Cancer Biotherapy & Radiopharmaceuticals
(4)
Cytometry
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT

Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model

The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer

A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells

Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival

Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells

Inappropriate activation of androgen receptor by relaxin via β-catenin pathway

The Effect of Sirolimus on Prostate‐Specific Antigen (PSA) Levels in Male Renal Transplant Recipients Without Prostate Cancer

p53 in Prostate Cancer: Frequent Expressed Transition Mutations

Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors

Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions

Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples

Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia

Dehydroepiandrosterone Activates Mutant Androgen Receptors Expressed in the Androgen-Dependent Human Prostate Cancer Xenograft CWR22 and LNCaP Cells

Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy

Inhibition of Akt pathways in the treatment of prostate cancer

Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer

Inappropriate activation of androgen receptor by relaxin via -catenin pathway

Tuberculous Spondylitis as A Complication of Intravesical Bacillus Calmette-Guerin Therapy

BCL2 antisense transcripts decrease intracellular Bcl2 expression and sensitize LNCaP prostate cancer cells to apoptosis-inducing agents

Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation

Urinary Prostate Specific Antigen Levels: Role in Monitoring the Response of Prostate Cancer to Therapy

Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas

The Predictive Value of Flow Cytometric Information in the Clinical Management of Stage O (Ta) Bladder Cancer

Future prospects in prostate cancer

Suchergebnisse filtern